Gossamer Bio Inc (GOSS)

Dec 16, 2024

The Manufacturers Life Insurance Company Boosts Stock Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Dec 16, 2024

Dec 03, 2024

US Penny Stocks: 3 Picks With Market Caps Under $200M - Simply Wall St

Dec 03, 2024

Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio - The Manila Times

Dec 02, 2024

Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the - GlobeNewswire

Dec 02, 2024

Dec 02, 2024

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio - Benzinga

Dec 02, 2024

Nov 29, 2024

Gossamer Bio: Q3 Earnings Snapshot - Marketscreener.com

Nov 29, 2024

Nov 26, 2024

Adicet Bio Inc (NASDAQ: ACET) – Analysts’ Revisions Point To Positive Sentiment - Stocks Register

Nov 26, 2024

Nov 26, 2024

GSA Capital Partners LLP Invests $67,000 in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Nov 26, 2024

Nov 25, 2024

Gossamer Bio Inc (GOSS)Monday, Aug 26, 2024 - Smartkarma

Nov 25, 2024

Nov 22, 2024

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy - MSN

Nov 22, 2024

Nov 19, 2024

US Bancorp DE Makes New $39,000 Investment in Gossamer Bio, Inc. (NASDAQ:GOSS) - Defense World

Nov 19, 2024

Nov 15, 2024

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Leerink Partnrs Raises Earnings Estimates for Gossamer Bio - Defense World

Nov 15, 2024

Nov 14, 2024

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

HC Wainwright Increases Earnings Estimates for Gossamer Bio - MarketBeat

Nov 13, 2024

Nov 13, 2024

FMR LLC's Strategic Acquisition of Gossamer Bio Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts - Yahoo Finance

Nov 12, 2024

Nov 12, 2024

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 12, 2024

Nov 11, 2024

Gossamer Bio Grants 183K Stock Options to New Hires at $0.88 Per Share | GOSS Stock News - StockTitan

Nov 11, 2024

Nov 11, 2024

Gossamer Bio (NASDAQ:GOSS) Earns Buy Rating from HC Wainwright - MarketBeat

Nov 11, 2024

Nov 10, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance

Nov 10, 2024

Nov 08, 2024

Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations - TipRanks

Nov 08, 2024

Nov 07, 2024

GOSSGossamer Bio, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024

Nov 07, 2024

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update - Business Wire

Nov 07, 2024

Oct 30, 2024

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now - The Manila Times

Oct 30, 2024

Oct 30, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Update - MarketBeat

Oct 30, 2024

Oct 30, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Sees Large Decline in Short Interest - Defense World

Oct 30, 2024

Oct 29, 2024

Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity - Yahoo Finance

Oct 29, 2024

Oct 28, 2024

3 US Penny Stocks With Market Caps Under $900M To Consider - Simply Wall St

Oct 28, 2024

Oct 18, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Bought by The Manufacturers Life Insurance Company - Defense World

Oct 18, 2024

Oct 17, 2024

Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail

Oct 17, 2024

Oct 15, 2024

It makes sense and dollars to buy Gossamer Bio Inc (GOSS) stock - SETE News

Oct 15, 2024

Oct 14, 2024

Financial Fitness Check: Examining Gossamer Bio Inc (GOSS)’s Key Ratios - The Dwinnex

Oct 14, 2024

Oct 14, 2024

Gossamer Bio Inc (GOSS) rating initates by Oppenheimer - Knox Daily

Oct 14, 2024

Oct 12, 2024

Millennium Management LLC Sells 898,042 Shares of Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat

Oct 12, 2024

Oct 12, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Shares Sold by Millennium Management LLC - MarketBeat

Oct 12, 2024

Oct 09, 2024

The Attractiveness of Investing In Gossamer Bio Inc (GOSS) is Growing - Knox Daily

Oct 09, 2024

Oct 09, 2024

Investor’s Delight: Gossamer Bio Inc (GOSS) Closes Weak at 1.02, Down -2.86 - The Dwinnex

Oct 09, 2024

Oct 09, 2024

GOSS underperforms with a -2.86 decrease in share price - US Post News

Oct 09, 2024

Oct 07, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - BioSpace

Oct 07, 2024

Oct 04, 2024

Gossamer Bio Inc [NASDAQ: GOSS] Sees Decrease in Stock Value - Knox Daily

Oct 04, 2024

Oct 04, 2024

Marshall Wace LLP Boosts Position in Gossamer Bio, Inc. (NASDAQ:GOSS) - MarketBeat

Oct 04, 2024

Oct 03, 2024

Several Insiders Invested In Gossamer Bio Flagging Positive News - Yahoo Finance

Oct 03, 2024

Oct 03, 2024

Analyzing Northwest Biotherapeutics (OTCMKTS:NWBO) and Gossamer Bio (NASDAQ:GOSS) - Defense World

Oct 03, 2024

Oct 02, 2024

Navigating GOSS’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle

Oct 02, 2024

Oct 02, 2024

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - Yahoo Finance

Oct 02, 2024

Oct 01, 2024

A better buy-in window may exist right now for Gossamer Bio Inc (GOSS) - SETE News

Oct 01, 2024

Sep 30, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.8% in September - Defense World

Sep 30, 2024

Sep 30, 2024

Analysts review Gossamer Bio Inc’s rating - Knox Daily

Sep 30, 2024

Sep 30, 2024

GOSS (Gossamer Bio Inc) has impressive results - US Post News

Sep 30, 2024